RESUMO
Helium is known to reduce airflow limitation. Our hypothesis was that severe COPD patients undertaking exercise would show greater improvement in endurance under a heliox mixture (80/20%) than under air alone. This hypothesis was tested in a double-blinded, randomized study. METHODS: Out of the 53 patients included, 45 were randomly assigned to two groups : Heliox (n= 23) and Air (n= 22). Patients were assessed with spirometry under air and heliox, incremental exercise test, constant workload (80% Wmax) exercise test and weekly 6-minute walk test. The two groups went through fifteen 30-minute retraining sessions in the overall framework of an identical pulmonary rehabilitation program. RESULTS: There was no significant difference in endurance improvement (Heliox : +52.5 sec, Air:+114sec, median value). FEV1 improvement under heliox exceeding 10% identified a group of 20 patients as "helium responders", who improved their endurance time by a median of 135sec compared to 50sec for the "non-responders" (non-significant difference). CONCLUSION: In patients with severe COPD, use of Heliox in exercise retraining did not produce significantly improved endurance. On the other hand, "helium responders" showed more FEV1 improvement than non-responders. Improved FEV1 under heliox should therefore be used in future studies as an inclusion criterion.
Assuntos
Hélio , Doença Pulmonar Obstrutiva Crônica , Teste de Esforço , Hélio/uso terapêutico , Humanos , Oxigênio , Doença Pulmonar Obstrutiva Crônica/reabilitaçãoRESUMO
INTRODUCTION: Therapeutic patient education (TPE) is an essential component of pulmonary readaptation in chronic respiratory diseases. Numerous and varied patient education projects offer heterogeneous contents and methods, which render them difficult to analyze and to compare. The objective of this review was to provide perspective on the main principles of patient education, using a non-exhaustive approach. STATE OF KNOWLEDGE: This review is focused on patient education using a patient-centered approach, physician-patient partnership and self-management, which are presented at once pragmatically and conceptually. One of the main objectives of TPE is the acquisition of self-management skills by patients with a chronic disease, which will be considered from a clinical standpoint. Lastly, TPE will be assessed in the overall framework of patient-centered pulmonary readaptation. PERSPECTIVES: TPE needs to be structured in view of assessing its effects. It is consequently essential for caregivers to receive continuous training so as to more clearly understand the methods employed, the objective being to build evaluable contents contributing to performance of multicentric trials. CONCLUSION: Current literature on TPE emphasizes the extent to which the patient remains the central actor in his or her care pathway. If patients are called upon to modify their behaviors, it is equally necessary that caregivers proceed likewise, adopting postures favoring the acquisition and appropriation by the patient of skills that shall be required as he or she learns to live with chronic disease.
Assuntos
Cuidadores , Educação de Pacientes como Assunto , Doença Crônica , Feminino , Humanos , MasculinoRESUMO
Despite effectiveness and clear international guidelines, respiratory rehabilitation remains underutilized: less than 15% of suitable patients in France and worldwide receive this treatment. The factors of this lack of referral and uptake have been studied and are not limited to a problem of quantitative adequacy of supply and demand. The lack of knowledge of health professionals, patients, payers, heterogeneous programs which does not necessary correspond to the needs of the patient (modalities, geography, duration), the lack of trained and available professionals, the profile of patients and prescribers and the quality of the programs are identified as potentially hindering the completion of a rehabilitation program. It is essential to analyze these barriers and to find solutions to the greatest number of respiratory patients can benefit optimal healthcare and integrate into a coherent care planning.
Assuntos
Acessibilidade aos Serviços de Saúde , Doença Pulmonar Obstrutiva Crônica , Encaminhamento e Consulta , França , HumanosRESUMO
BACKGROUND: Breathlessness is the prominent symptom of chronic obstructive pulmonary disease (COPD). Despite optimal therapeutic management including pharmacological and non-pharmacological interventions, many COPD patients exhibit significant breathlessness. Chronic breathlessness is defined as breathlessness that persists despite optimal treatment of the underlying disease. Because of the major disability related to chronic breathlessness, symptomatic treatments including opioids have been recommended by several authors. The prevalence of chronic breathlessness in COPD and its management in routine clinical practice have been poorly investigated. Our aim was to examine prevalence, associated characteristics and management of chronic breathlessness in patients with COPD recruited in a real-life tertiary hospital-based cohort. METHODS: A prospective study was conducted among 120 consecutive COPD patients recruited, in stable condition, at Nancy University Hospital, France. In parallel, 88 pulmonologists of the same geographical region were asked to respond to an on-line questionnaire on breathlessness management. RESULTS: Sixty four (53%) patients had severe breathlessness (modified Medical Research Council scale≥3), despite optimal inhaled medications for 94% of them; 40% had undergone pulmonary rehabilitation within the past 2 years. The severity of breathlessness increased with increasing airflow limitation. Breathlessness was associated with increased symptoms of anxiety, depression and with osteoporosis. No relation was found with other symptoms, exacerbation rate, or cardiovascular comorbidities. Among the patients with chronic breathlessness and Hospitalized Anxiety and/or Depression score > 10, only 25% were treated with antidepressant or anxiolytic. Among the pulmonologists 46 (52%) answered to the questionnaire and expressed a high willingness to prescribe opioids forchronic breathlessness, which contrasted with the finding that none of these patients received such treatments against breathlessness. CONCLUSION: Treatment approaches to breathlessness and associated psychological distress are insufficient in COPD. This study highlights underuse of pulmonary rehabilitation and symptomatic treatment for breathlessness.
Assuntos
Analgésicos Opioides/uso terapêutico , Dispneia/tratamento farmacológico , Dispneia/epidemiologia , Doença Pulmonar Obstrutiva Crônica/complicações , Idoso , Doença Crônica , Feminino , França/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Padrões de Prática Médica , Prevalência , Estudos Prospectivos , Pneumologistas , Qualidade de Vida , Índice de Gravidade de Doença , Inquéritos e Questionários , Centros de Atenção TerciáriaAssuntos
Serviços de Saúde Comunitária/normas , Doença Pulmonar Obstrutiva Crônica/patologia , Doença Pulmonar Obstrutiva Crônica/terapia , Doença Aguda , Terapias Complementares/métodos , Terapias Complementares/normas , Progressão da Doença , Humanos , Ventilação não Invasiva/normas , Ventilação não Invasiva/estatística & dados numéricos , Equipe de Assistência ao PacienteRESUMO
Chronic obstructive pulmonary disease (COPD) is the chronic respiratory disease with the most important burden on public health in terms of morbidity, mortality and health costs. For patients, COPD is a major source of disability because of dyspnea, restriction in daily activities, exacerbation, risk of chronic respiratory failure and extra-respiratory systemic organ disorders. The previous French Language Respiratory Society (SPLF) guidelines on COPD exacerbations were published in 2003. Using the GRADE methodology, the present document reviews the current knowledge on COPD exacerbation through 4 specific outlines: (1) epidemiology, (2) clinical evaluation, (3) therapeutic management and (4) prevention. Specific aspects of outpatients and inpatients care are discussed, especially regarding assessment of exacerbation severity and pharmacological approach.
Assuntos
Doença Pulmonar Obstrutiva Crônica/terapia , Reação de Fase Aguda , Progressão da Doença , França , Humanos , Idioma , Doença Pulmonar Obstrutiva Crônica/epidemiologia , Doença Pulmonar Obstrutiva Crônica/patologia , Qualidade de Vida , Índice de Gravidade de Doença , Sociedades Médicas/normas , Análise de SobrevidaAssuntos
Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Pneumopatias/reabilitação , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Transtornos Respiratórios/reabilitação , Estudos Transversais , França , Humanos , Pneumopatias/epidemiologia , Transtornos Respiratórios/epidemiologia , Revisão da Utilização de Recursos de Saúde/estatística & dados numéricosRESUMO
The authors report a study of 140 patients presenting with a non-allergic respiratory tract disease (121 cases of asthma--19 cases of spasmodic cough). Gastro-oesophageal reflux was detected by 24-hour pHmetry in 86 of these patients. In 34 of them (i.e. 40% of cases), the gastro-oesophageal reflux appeared to be responsible for the initial respiratory tract symptoms. These 34 patients were submitted to a therapeutic trial of high dose anti-H2 therapy for at least two months. Only those patients in whom a marked improvement or even complete resolution of the respiratory tracts symptoms was observed underwent anti-reflux surgery. Out of the 13 patients undergoing surgery, there were two failures and 11 good results after a follow-up of more than 18 months.
Assuntos
Asma/etiologia , Tosse/etiologia , Refluxo Gastroesofágico/complicações , Feminino , Refluxo Gastroesofágico/diagnóstico , Refluxo Gastroesofágico/cirurgia , Humanos , Concentração de Íons de Hidrogênio , Masculino , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios XRESUMO
The advantages of long-term administration of vasodilators in the treatment of chronic cor pulmonale were investigated after informed consent in 60 patients with obstructive respiratory insufficiency (56 men, 4 women, mean age 63.5 +/- 1.5 years; mean pulmonary pressure 30.4 mm Hg). They were randomly divided into two groups of 30, a control group and a group treated with nifedipine, 10 mg three times a day. The following parameters were recorded every 3 months for a year: dyspnea, degree of right ventricular failure, number of days spent in hospital, survival and arterial blood gas tension. On the first day of study, no significant difference existed between the control and the treated groups. After 1 year 22 patients in the control group were still followed and 8 were dead. In the treated group 19 were followed, 7 were dead and 4 stopped treatment, generally due to ankle edema. At the end of the study, the only significant modification was improvement of the dyspnea in the nifedipine group (p less than 0.01). In conclusion, in spite of an improvement in the dyspnea index, clinical study for 1 year failed to demonstrate any objective benefit of nifedipine treatment.
Assuntos
Hipertensão Pulmonar/tratamento farmacológico , Pneumopatias Obstrutivas/complicações , Nifedipino/uso terapêutico , Idoso , Ensaios Clínicos como Assunto , Dispneia/tratamento farmacológico , Feminino , Humanos , Hipertensão Pulmonar/complicações , Masculino , Pessoa de Meia-IdadeRESUMO
The authors describe their experience with 1222 tracheobronchial endoscopic laser resections. The technique uses the thermal effects of the YAG laser which can be set to produce coagulation and vaporization. In most cases, the rigid bronchoscope under general anesthesia was preferred to the flexible fiberscope under local anesthesia. The main reason for this preference is that the rigid system allows management of hemorrhage should it occur. The technique is described with special attention to prevention of hypoxia, the major hazard. Inoperable malignant tumors accounted for 50% of the procedures. The other indications were tumors with uncertain prognosis, benign tumors, tracheal stenosis, and miscellaneous lesions. Results depend greatly on location. No fatality was recorded during the procedure, but two deaths did occur in the 48 hours thereafter. The authors conclude that endoscopic laser resection is a very effective modality for obstructive lesions in the main airways. It can be repeated as many times as needed and may be associated with other forms of therapy.